TickerFacts.

Summit Therapeutics Inc. (SMMT): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$322.93M
Year ended 2025-12-31
-$458.43M
Trailing 12 months to 2026-06-30
2019-01-31: -$35.11M2020-12-31: -$48.11M2021-12-31: -$72.59M2022-12-31: -$41.58M2023-12-31: -$76.76M2024-12-31: -$142.11M2025-12-31: -$322.93M-$322.93M
2019-01-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$322.93Mn/m2026-02-23, From 2025-01-01
2024-12-31-$142.11Mn/m2026-02-23, From 2024-01-01
2023-12-31-$76.76Mn/m2026-02-23, From 2023-01-01
2022-12-31-$41.58Mn/m2025-02-24, From 2022-01-01
2021-12-31-$72.59Mn/m2023-03-09, From 2021-01-01
2020-12-31-$48.11Mn/a2022-12-21, From 2020-01-01
No annual figure between 2019-01-31 and 2020-12-31.
2019-01-31-$35.11Mn/a2021-03-31, From 2018-02-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Summit Therapeutics Inc. (SMMT)2025-12-31-$322.93Mn/m
Aurinia Pharmaceuticals Inc. (AUPH)2025-12-31$135.66M+205.6%
Kiniksa Pharmaceuticals International, plc (KNSA)2025-12-31$137.99M+437.1%
Kura Oncology, Inc. (KURA)2025-12-31-$64.06Mn/m
Cryoport, Inc. (CYRX)2025-12-31-$8.58Mn/m
Vera Therapeutics, Inc. (VERA)2025-12-31-$241.10Mn/m
NewAmsterdam Pharma Co N.V. (NAMS)2025-12-31-$147.78Mn/m
Maravai Lifesciences Holdings, Inc. (MRVI)2025-12-31-$57.57Mn/m
Schrodinger, Inc. (SDGR)2025-12-31$13.90Mn/m

Compare SMMT, AUPH, KNSA, KURA side by side · Screen every company in Pharmaceutical Preparations ↗